PureStem NMN

NMN, which is involved in the synthesis of NAD+, is manufactured domestically.
freeze-driedas a product.

PureStem NMN is a freeze-dried product containing 300 mg of β-nicotinamide mononucleotide (NMN) per unit.

We verify the purity and quality standards of our raw materials and provide product information and handling guidelines specifically for medical institutions.

Inquire about our products
PureStem NMN 300mg

Supporting the production of NAD+...
...is its precursor, NMN.

NMN serves as a building block for the synthesis of NAD+ within the body—a molecule essential for cellular energy metabolism.

NMN (nicotinamide mononucleotide) is a substance naturally present in our bodies and acts as a precursor used to produce NAD+.

NAD+ is involved in various cellular functions, including the process by which cells generate energy from nutrients and the activity of enzymes responsible for DNA repair.

As a substance involved in NAD+ metabolism, NMN is currently the subject of research regarding its relationship to aging and health.

Image of a molecule representing an NAD+ precursor

A precursor to NAD+

NMN is one of the building blocks used by the body to synthesize NAD+.

Image of a mitochondrion representing energy metabolism

Connection to energy metabolism

It is involved in cellular energy metabolism via NAD+.

Image of a DNA double helix representing aging research

Connection to aging research

Research is being conducted on the relationship between changes in NAD+ metabolism and aging.

A freeze-dried preparation,
designed with product quality and handling in mind.

Features raw materials with a purity of 99.0% or higher, and is freeze-dried and manufactured domestically.

PureStem NMN is a freeze-dried product containing 300 mg of β-nicotinamide mononucleotide per unit.

Manufactured domestically using raw materials with a purity of 99.0% or higher.

Information regarding product specifications, quality standards, and storage conditions is available for medical institutions.

300 mg per unit

Contains 300 mg of NMN per unit.

Purity of 99.0% or higher

Clearly defined purity standards for raw materials.

Freeze-dried preparation

Processed via freeze-drying (lyophilization).

Clearly defined product specifications and quality.

Comprehensive product information—from raw material standards to storage conditions.

Product Specifications

ItemSpecifications
Product namePureStem NMN
Net Content300 mg per unit
Ingredientsβ-nicotinamide mononucleotide
AppearanceWhite to pale yellow powder
Product formFreeze-dried (recrystallized) product
Country of manufactureJapan
Storage conditionsStore in a cool, dark place, away from direct sunlight
Handling after openingAvoid moisture absorption; use promptly.
Expiration date2 years from the date of manufacture

Raw Material Quality Specifications

Test ItemSpecification Limit
NMN purity≥ 99.0%
Arsenic≤ 0.1 ppm
Lead≤ 0.05 ppm
Cadmium≤ 0.01 ppm
Heavy Metals≤ 0.5 ppm
Total Aerobic Microbial CountNot detected
Coliform BacteriaNegative
Staphylococcus aureusNegative

The above represents raw material quality specifications and does not indicate the actual measured values ​​for specific lots of the finished product.

Regarding NMN, health, and aging:
The current state of research.

Human clinical studies on NMN safety, NAD+ metabolism, and physical function serve as scientific background information.

NMN is a precursor used in the body for the synthesis of NAD+.

In recent years, clinical studies on the oral intake of NMN have been conducted, involving healthy adults and older individuals.

These studies have evaluated factors such as safety, NAD+-related metabolites, physical function, and insulin sensitivity.

However, many of these studies have limited sample sizes and observation periods; therefore, further verification is required regarding long-term efficacy and safety.

Healthy Japanese men – Single oral administration

Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men

Author(s)
Junichiro Irie, Emi Inagaki, Masataka Fujita, et al.
Publication
Endocrine Journal 67(2), 153–160 (2020)
Evaluation
Assessment of safety, clinical indicators, and nicotinamide metabolites following a single oral dose of 100 mg, 250 mg, or 500 mg.
DOI
10.1507/endocrj.EJ19-0313
View References

Healthy elderly men – Sustained oral administration

Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men

Author(s)
Masaki Igarashi, Yoko Nakagawa-Nagahama, Miki Miura, et al.
Publication
npj Aging 8, Article 5 (2022)
Evaluation
Assessment of blood-based NAD+ metabolites, physical function, and indicators related to muscle function following oral administration.
DOI
10.1038/s41514-022-00084-z
View References

Postmenopausal women with prediabetes – Sustained oral administration

Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women

Author(s)
Mihoko Yoshino, Jun Yoshino, Brandon D. Kayser, Gary J. Patti, et al.
Publication
Science 372(6547), 1224–1229 (2021)
Evaluation
Assessment of skeletal muscle insulin sensitivity and related metabolic markers following a daily oral intake of 250 mg for 10 weeks.
DOI
10.1126/science.abe9985
View References

The studies cited here provide general research information regarding the oral administration of NMN. They do not constitute proof of the efficacy or safety of the "PureStem NMN 300mg" product itself. Furthermore, these findings do not imply that similar results would be achieved through intravenous administration.

For product inquiries,
please contact us.

We provide information—such as product specifications, raw material quality standards, and handling requirements—tailored to your specific inquiries.

Inquire about our products